|
|
 |
|
Viewing report
|
|
|
|
HIV - A Way Of Life
Datamonitor, Oct 2005, Pages: 284
Introduction
HIV is now considered a chronic, manageable disease. However the lifelong therapy required to control HIV means considerations such as
patient quality of life and cost of therapy are becoming increasingly influential in product choice. Consequently the development of new products which offer limited improvements in efficacy but better convenience and tolerability has changed prescription practices
Scope
- Analysis of current treatment regimens and unmet needs, based on a survey of 180 physicians in the seven major pharma markets around the world
- Current epidemiology of HIV in the seven major markets, including prevalence, age and gender splits, with analysis of diagnosis and chain of care
- A detailed examination of the numbers of patients on each line of therapy, which drugs they are taking and for what reasons is provided
An assessment of key unmet needs within HIV and the changes in mortality since the introduction of HAART is included
Highlights
Increasing transmission by heterosexual contact suggests both an absence and/or ineffectiveness of HIV awareness and education programs. It also exposes more females to the HIV virus, leading to unique disease management issues.
The success of HAART in prolonging survival within the HIV population introduces new psychosocial challenges beyond pharmaceutical management. Age-related conditions, comorbidities and the desire to conceive call for a new multi-faceted pattern of patient care
Datamonitor physician research indicates that of 273,000 first-line treated individuals, globally 79% are now receiving fixed dosed combinations (FDCs). While guidelines and HIV specialists have embraced their convenience and simplicity, the unstructured nature of later lines of therapy requires increasing individualization
Reasons to Purchase
- Understand the unique disease management issues raised by increasing heterosexual transmission of HIV to females
- Identify opportunities for new patterns of patient care following the success of HAART in prolonging survival
- Explore unmet needs in HIV therapy, as identified by treating physicians, and including increased individualization in later-line therapy
Customers who bought this item also bought
Stakeholder Insight: HIV Therapy Dynamics
Pipeline Insight: HIV - Novel NNRTIs address crucial unmet need
Pipeline Insight: HIV - The Age of Convenience
HIV - Simplicity And Survival
Pipeline Insight: HIV - Extending Treatment Options
Commercial Insight: HIV - Simplicity and Survival
Commercial Insight: HIV - Reshaping Treatment Paradigms
Pipeline Insight: HIV - Hold Your Horses
The Global HIV/AIDS Market Outlook to 2012
Global HIV Market: An Analysis
The Medical Management of HIV/AIDS
HIV - Benchmarking Rapid Antiretroviral Uptake
|
|
|
|
